- Multimedia -

2009 HAI Consensus Development Conference: Process and Technology Strategies for Prevention of Catheter-Related Bloodstream Infections

Activity Description Highlights from the 2009 Consensus Conference on Healthcare Associated Infections (HAIs) have been captured in this multimedia continuing education activity. The prevention of HAIs is a major concern in nearly all facets of healthcare delivery, and their impact receives keen attention from hospital-based practitioners and administrators, as well as regulators, payers, and patient advocacy groups. The purpose of this 1.5-day Consensus Conference was to review the causes, prevalence, and impact of HAIs in general, and then focus more intensively on Progress and Technology Strategies for Prevention of Catheter-Related Bloodstream Infections particularly those linked to the use of central venous catheters. The ultimate goal was to develop a Consensus Statement on the prevention of central line associated bloodstream infections (CLABSIs) that would be broadly disseminated for the purposes of education, clinical implementation, and reducing rates of infection. This 3-hour activity will provide a summary of several expert presentations that were delivered at the HAI Conference. This activity also includes key points from the Consensus Statement on the prevention of CLABSIs that was developed during the conference, owing to the combined efforts of the presenters, attendees, and the Consensus Advisory Panel. This Statement will be published in the medical literature in 2010.

Learning Objectives

Upon completion of this activity, pharmacists, nurses, and physicians will be able to:

• Restate the current epidemiology of healthcare associated infections (HAIs), sources of infection, and general strategies for prevention

• List direct and indirect costs attributable to HAIs, including central line associated bloodstream infections (CLABSI)

• Summarize the regulatory implications of institutional adherence to infection prevention initiatives

• Describe evidence-based best practices, including simultaneous process and technology improvements, for the prevention of CLABSI

• Analyze the training, educational, and supervisory needs of nursing staff needed to maintain HAI detection and prevention efforts

• Describe the technological, infrastructure, and other resources needed for improved surveillance, prevention, control, and reporting of CLABSI

• Utilize consensus recommendations for support in implementing practice changes intended to improve quality of care and reduce infection risks related to central line catheter use

Faculty

Chairman
John Segreti, MD
Professor, Section of Infectious Diseases
Rush University Medical Center
Chicago, IL

Consensus Panel Member **

** Sylvia Garcia-Houchins, RN, MBA, CIC
Director, Infection Control Program
University of Chicago Medical Center
Chicago, IL

** Lisa Gorski, MS, APRN, BC, CNI, FAAN
Clinical Nurse Specialist
Wheaton Healthcare
Milwaukee, WI

** Nancy Moureau, BSN, CRNI
PICC Excellence
Rincon, GA

** Julie Shomo, BS, BSN, RN, CRNI
President
Infusion Solutions
Columbus, OH

Barbara M. Soule, RN, MPA, CIC
CIC Practice Leader
Infection Prevention Services
Joint Commission Resources
Oak Brook, IL

Marc-Oliver Wright, MT, MS, CIC
Director of Infection Control
NorthShore University Health System
Evanston, IL

** Jeanne Zack, PhD, RN, CIC
Manager Infection Prevention Control
Missouri Baptist Medical Center
St. Louis, MO

Disclosure

It is the policy of ProCE, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Dr. John Segreti, Ms. Barbara M. Soule, and Mr. Marc-Oliver Wright have reported that they have no significant financial or commercial relationships to disclose.

The following individuals have reported having a financial and/or commercial relationship to disclose.

Ms. Sylvia Garcia-Houchins: Consultant/Speaker: CareFusion, Joint Commission Resources

Ms. Lisa Gorski: Consultant/Speaker: Bard Medical Systems, Genentech.

Ms. Nancy Moureau: Speaker: Access Scientific, Cook, Hospira, Vygon. Consultant: Access Scientific, Angiodynamics, CareFusion, Excelsior, R4, Sonosite, Teleflex Medical, 3M.

Ms. Julie Shomo: Consultant/Speaker: Cardinal Health, Hospira, OMI, PharMerica.

Dr. Jeanne Zack: Consultant/Speaker: CareFusion

Please note: The information and views presented in this CE activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications. Use of drugs and/or devices outside of labeling should be considered experimental. Participants are advised to consult and verify manufacturer product information, the professional literature and use his/her professional judgment in applying the presented information in patient care activities.

CME/CE Accreditation

Release Date: 07-01-2010
Expiration Date: 07-01-2013

Pharmacists:
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-000-10-027-H05-P has been assigned to this home study, knowledge-based activity. This activity is acceptable for 3.0 contact hours (0.30 CEUs) in states that recognize ACPE providers.

Physicians:
This activity has been planned and implemented in accordance with the essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of ProCE, Inc. and the National Association of Managed Care Physicians (NAMCP). The NAMCP is accredited by the ACCME to provide continuing medical education (CME) to physicians. The NAMCP designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses:
Nurse CE is provided for this activity through collaboration between ProCE, Inc. and Wild Iris Medical Education, Inc. Wild Iris Medical Education, Inc. is accredited as a provider of continuing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 3.0 contact hours of nurse CE credit.

Funding

This activity is supported by an educational grant from Hospira, Inc.